Nanocarriers for Inner Ear Disease TherapyShow others and affiliations
2021 (English)In: Frontiers in Cellular Neuroscience, E-ISSN 1662-5102, Vol. 15, article id 791573
Article, review/survey (Refereed) Published
Abstract [en]
Hearing loss is a common disease due to sensory loss caused by the diseases in the inner ear. The development of delivery systems for inner ear disease therapy is important to achieve high efficiency and reduce side effects. Currently, traditional drug delivery systems exhibit the potential to be used for inner ear disease therapy, but there are still some drawbacks. As nanotechnology is developing these years, one of the solutions is to develop nanoparticle-based delivery systems for inner ear disease therapy. Various nanoparticles, such as soft material and inorganic-based nanoparticles, have been designed, tested, and showed controlled delivery of drugs, improved targeting property to specific cells, and reduced systemic side effects. In this review, we summarized recent progress in nanocarriers for inner ear disease therapy. This review provides useful information on developing promising nanocarriers for the efficient treatment of inner ear diseases and for further clinical applications for inner ear disease therapy.
Place, publisher, year, edition, pages
Frontiers Media SA , 2021. Vol. 15, article id 791573
Keywords [en]
nanocarrier, drug delivery system, inner ear disease therapy, soft material nanoparticle, inorganic nanoparticle
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:kth:diva-306766DOI: 10.3389/fncel.2021.791573ISI: 000731018200001PubMedID: 34924960Scopus ID: 2-s2.0-85121379067OAI: oai:DiVA.org:kth-306766DiVA, id: diva2:1623785
Note
QC 20211230
2021-12-302021-12-302023-02-22Bibliographically approved